4 min read
ASCO 2026: RAS Is No Longer Undruggable
For decades, oncologists and drug developers shared an undeniable truth: KRAS – one of the most commonly mutated genes...
Every spring, Veristat attends and participates in the MassBio Annual Meeting and 2018 is no different. This year’s event will draw together more than 400 biopharma industry leaders and stakeholders to discuss timely and critical challenges facing the biopharma industry today, not only in Massachusetts, but around the world.
This year’s agenda highlights the following:
- Diversity in Leadership
- Health Economics
- Venture Capital: traditional, corporate and family offices
- Tenacity in Biotechnology
- Regenerative Technologies
- Opioids
- Digital Currency
- Physicians and Clinicians
- and more.
Connect with Veristat at The MassBio Annual Meeting 2018
Fill out the form on the right hand side of this page to connect with Veristat at this meeting or anytime.
Learn More About the Meeting or Register:
Please visit the MassBio website to get more details or register for this event.